Integrated Filing — IndAS



General information about company

Scrip Code 544339
NSE Symbol LAXMIDENTL
MSEI Symbol NOTLISTED
ISIN INE0WO601020
Name of company Laxmi Dental Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 21-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 18-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Integrated Dental Products
Start date and time of board meeting 21-05-2026   16:00:00
End date and time of board meeting 21-05-2026   19:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 26-03-2026
Indicate Company website link for updated RPT policy of the Company https://www.laxmidentallimited.com/public/investors/policies/new/Related%20Party%20Transaction%20Policy.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 5,573.60 20,855.60
Other income 199.00 802.60
Total income 5,772.60 21,658.20
2 Expenses
(a) Cost of materials consumed 1,763.30 4,829.50
(b) Purchases of stock-in-trade 330.70 2,090.80
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (307.50) (116.20)
(d) Employee benefit expense 2,185.40 7,887.80
(e) Finance costs 27.30 78.30
(f) Depreciation, depletion and amortisation expense 333.00 1,151.40
(f) Other Expenses
1 Other Expenses 782.30 3,124.00
Total other expenses 782.30 3,124.00
Total expenses 5,114.50 19,045.60
3 Total profit before exceptional items and tax 658.10 2,612.60
4 Exceptional items 0.00 (515.60)
5 Total profit before tax 658.10 2,097.00
6 Tax expense
7 Current tax (47.60) 541.60
8 Deferred tax 9.90 (87.30)
9 Total tax expenses (37.70) 454.30
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 695.80 1,642.70
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method (16.00) 291.00
16 Total profit (loss) for period 679.80 1,933.70
17 Other comprehensive income net of taxes 51.30 8.70
18 Total Comprehensive Income for the period 731.10 1,942.40
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,099.20 1,099.20
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 23,605.80
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.24 3.52
Diluted earnings (loss) per share from continuing operations 1.24 3.52
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.24 3.52
Diluted earnings (loss) per share from continuing and discontinued operations 1.24 3.52
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1 The standalone audited financial results of the Company for the year ended 31 March 2026 have been prepared in accordance with the Indian Accounting Standards (“Ind AS”) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The aforesaid results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 21 May 2026. The Statutory Auditors of the Company have carried out an audit of the above results and have expressed an unmodified opinion. 2 The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures in respect of the full financial year and the published year-to-date figures up to the third quarter of the respective financial years. 3 As permitted by paragraph 4 of Indian Accounting Standard (Ind AS) 108 “Operating Segments”, notified under Section 133 of the Companies Act, 2013, read together with the relevant rules issued thereunder, if a single financial report contains both consolidated financial statements and the separate financial statements of the parent, segment information need to be presented only on the basis of the consolidated financial statements. Thus, disclosure required by Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 on segment wise revenue results and capital employed are given in consolidated financial results. 4 On 7 May 2024, the Company sold one of its investment properties for a total sale consideration of INR 101 million. The book value of the said property as on the date of sale was INR 7.10 million. Accordingly, the Company recognized a gain on sale of investment property amounting to INR 93.90 million. The tax expense arising from the transaction was initially computed at INR 27.73 million, and the net gain (after tax) of INR 66.17 million was disclosed as an exceptional gain in the financial statements for the period ended 31 December 2024. During the year ended 31 March 2025, the Company opted to avail the benefit under Section 115BAA of the Income-tax Act, 1961, which resulted in a change in the applicable tax rate. Consequently, the net tax effect on the aforesaid transaction was revised to INR 23.64 million, and the net exceptional gain has been recomputed to INR 70.27 million in these financial results to reflect the impact of the revised tax rate. 5 Effective 21 November 2025, the Government of India consolidated 29 existing labour regulations into four Labour codes, namely, The Code on Wages, 2019, The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The New Labour Codes has resulted in material increase in provision for gratuity expenses on account of recognition of past service costs. Based on the requirements of New Labour Codes and relevant Accounting Standard, the Company has assessed and accounted the estimated incremental impact of INR 51.56 millions as an Exceptional Item in the standalone audited statement of financial results for the year ended 31 March 2026. Upon notification of the related Rules to the New Labour Codes by the Government and any further clarification from the Government on other aspects of the New Labour Codes, the Company will evaluate and account for additional impact if any, in subsequent periods. 6 The utilisation of the proceeds of initial public offer (IPO) as on 31 March 2026 is summarised as below: (INR in millions) Particulars Objects of the issue (as per offer document) Utilised upto 31-Mar-2026 Unutilised as on 31-Mar-2026 Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our company 229.84 229.84 - Investment in certain Subsidiaries for the repayment/ prepayment, in full or in part, of certain outstanding borrowings 46.00 46.00 - Funding of capital expenditure requirements for purchase of new machinery for our Company 435.07 135.02 300.05 Investments in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery 250.04 3.46 246.58 General Corporate purposes 320.75 320.75 - Total utilisation of funds 1,281.70 735.07 546.63 Out of the net proceeds which were unutilised as at 31 March 2026, INR 546.63 million are temporarily invested in fixed deposits with banks. The Company is in the process of obtaining an extension for the utilization of the IPO proceeds in the subsequent period. 7 During the year ended 31 March 2026, the Company has entered into an investment agreement with Laxmi Dental Lab USA INC, a subsidiary of the Company in the USA, for purchase of additional 10,000 equity shares at USD 100 per share, aggregating to USD 1,000,000 on 24 April 2025, to support working capital requirements and business growth. 8 During the year ended 31 March 2026, the Company has acquired additional shares in Bizdent Devices Private Limited (“BDPL”), its wholly owned subsidiary, by way of subscription to a rights issue of 8,93,334 equity shares at an issue price of INR 458 per share (comprising face value of INR 10 and securities premium of INR 448 per share), aggregating to INR 409.15 million on 29 April 2025. 9 During the year ended 31 March 2026, the Company has invested in IDBG AI Dent Global Private Limited (“IDBG AIDGPL”), resulting in acquisition of 11,175 equity shares of face value INR 10 each at a premium of INR 1,217.50 per share (representing 49% of the total equity share capital), for an aggregate consideration of INR 13.72 million. The Company has also subscribed to 5,123 Compulsory Convertible Preference Shares (CCPS) of IDBG AIDGPL, without voting rights, of face value INR 10 each at a premium of INR 1,217.50 per CCPS, aggregating to INR 6.29 million. 10 During the year ended 31 March 2026, the Board of Directors approved the Scheme of Merger of Bizdent Devices Private Limited, a wholly owned subsidiary, with the Company, Laxmi Dental Limited. The Scheme provides for merger to be effective from 1 April 2026, subject to receipt of requisite statutory and regulatory approvals. As the Scheme is currently awaiting approval from the appropriate authorities, no effect of the proposed merger has been given in these standalone financial results. 11 The standalone financial results of the Company are available on the Company's website (www.laxmidentallimited.com) and stock exchanges websites, BSE (www.bseindia.com) and NSE (www.nseindia.com), where the shares of the Company are listed.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 5,081.00
Capital work-in-progress 0.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 302.10
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 6,851.50
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 1,324.10
Total of other non-current financial assets 1,324.10
Total non-current financial assets 1,324.10
Deferred tax assets (net) 628.20
Other non-current assets
Total of other non-current assets
Total non-current assets 14,186.90
2 Current assets
Inventories 2,068.80
Current financial asset
Current investments 1,004.20
Trade receivables, current 3,099.40
Cash and cash equivalents 387.50
Bank balance other than cash and cash equivalents 113.90
Loans, current 109.50
Other current financial assets
Total of other current financial assets 6,149.60
Total current financial assets 10,864.10
Current tax assets (net) 264.40
Other current assets
1 Other current assets 1,491.40
Total of other current assets 1,491.40
Total current assets 14,688.70
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 28,875.60
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,099.20
Other equity 23,605.80
Total equity attributable to owners of parent 24,705.00
Non controlling interest
Total equity 24,705.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Other non-current financial liabilities 69.10
Total of other non-current financial liabilities 69.10
Total non-current financial liabilities 69.10
Provisions, non-current 808.20
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 841.00
Total of other non-current liabilities 841.00
Total non-current liabilities 1,718.30
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 194.70
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 641.50
Total Trade payable 836.20
Other current financial liabilities
1 Other current financial liabilities 724.30
Total of other current financial liabilities 724.30
Total current financial liabilities 1,560.50
Other current liabilities 688.50
1 Other current liabilities 688.50
Total of other current liabilities 688.50
Provisions, current 203.30
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 2,452.30
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 4,170.60
Total equity and liabilites 28,875.60
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement gain/(loss) of net defined benefit plan 68.50 11.60
Total Amount of items that will not be reclassified to profit and loss 68.50 11.60
2 Income tax relating to items that will not be reclassified to profit or loss 17.20 2.90
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 51.30 8.70



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,097.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0.00
Adjustments for decrease (increase) in inventories (401.60)
Adjustments for decrease (increase) in trade receivables, current 122.10
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets (424.60)
Adjustments for other financial assets, non-current (4,431.20)
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (2,015.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 570.40
Adjustments for depreciation and amortisation expense 1,151.40
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss (110.90)
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 217.80
Adjustments for unrealised foreign exchange losses gains (18.00)
Adjustments for dividend income 0.00
Adjustments for interest income 386.60
Adjustments for share-based payments 311.10
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 3.90
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 291.00
Total adjustments for reconcile profit (loss) (5,120.20)
Net cash flows from (used in) operations (3,023.20)
Dividends received 0.00
Interest paid (78.20)
Interest received 0.00
Income taxes paid (refund) 581.20
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (3,526.20)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 5,148.50
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 1,526.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 197.20
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 374.60
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,905.00
Net cash flows from (used in) investing activities (4,592.10)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 264.50
Dividends paid 0.00
Interest paid 78.30
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (342.80)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (8,461.10)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (8,461.10)
Cash and cash equivalents cash flow statement at beginning of period 8,848.50
Cash and cash equivalents cash flow statement at end of period 387.40





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K A & Associates Yes 31-07-2027


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 16-01-2025
Amount Raised 69,805.80
Report filed for Quarter ended 31-03-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA LIMITED
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our Company NA 2,298.40 0.00 2,298.40 0.00
2 Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. NA 460.00 0.00 460.00 0.00
3 Funding the capital expenditure requirements for purchase of new machinery for our Company. NA 4,350.70 0.00 1,350.20 0.00
4 Investment in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery. NA 2,500.40 0.00 34.60 0.00
5 General corporate purposes. NA 3,207.50 0.00 3,207.50 0.00


Signatory Details

Name of signatory SAMEER KAMLESH MERCHANT
Designation of person Managing Director
Place MUMBAI
Date 21-05-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Laxmi Dental Limited Mr. Rajesh Khakhar Whole time Director & Chairman Remuneration 135.00 Approved 93.00 7.00 8.00
2 Laxmi Dental Limited Mr. Sameer Merchant CEO and Managing Director Remuneration 135.00 Approved 93.00 7.00 8.00
3 Laxmi Dental Limited Mr. Dharmesh Dattani Chief Finance Officer Remuneration 110.00 Approved 63.00 4.50 5.50
4 Laxmi Dental Limited Mr. Rajesh Dalal Independent Director Remuneration 15.00 Approved 15.00 0.00 0.00
5 Laxmi Dental Limited Mrs. Anjana Grewal Independent Director Remuneration 15.00 Approved 15.00 0.00 0.00
6 Laxmi Dental Limited Mr. Devesh Chawla Independent Director Remuneration 75.00 Approved 7.50 0.00 0.00
7 Laxmi Dental Limited Mr. Anil Arora Non executive non-independent director Remuneration 75.00 Approved 4.40 0.00 0.00
8 Laxmi Dental Limited Mr. Parth Khakhar Relative of direcotrs And KMP Remuneration 100.00 Approved 93.50 7.50 7.80
9 Laxmi Dental Limited Mrs. Jigna R Khakhar Relative of direcotrs And KMP Remuneration 30.00 Approved 16.00 0.00 2.00
10 Laxmi Dental Limited Mr. Manan Khakhar Relative of direcotrs And KMP Remuneration 40.70 Approved 48.00 3.00 4.00
11 Laxmi Dental Limited MR. Hasmukh Khakhar Relative of direcotrs And KMP Remuneration 20.00 Approved 12.00 0.00 1.50
12 Laxmi Dental Limited Mr. Shubh Sanjay Khakhar Relative of direcotrs And KMP Remuneration 32.50 Approved 28.70 2.10 2.50
13 Laxmi Dental Limited Mrs. Bhavi Merchant Relative of direcotrs And KMP Remuneration 0.00 Approved 45.00 26-03-2026 16.00 0.00 2.00
14 Laxmi Dental Limited Ms. Siddhi Khakhar Relative of direcotrs And KMP Remuneration 35.00 Approved 21.00 0.00 2.50
15 Laxmi Dental Limited Mr. Rajesh Khakhar Whole time Director & Chairman Any other transaction Rent paid 7.60 Approved 7.40 0.00 0.00
16 Laxmi Dental Limited Mr. Rajesh Khakhar Whole time Director & Chairman Any other transaction Security Deposit 0.00 Approved 3.60 26-03-2026 0.00 3.60 3.60
17 Laxmi Dental Limited Laxmi Dental Lab USA INC Subsidiary Purchase of goods or services 58.00 Approved 202.70 26-03-2026 159.30 2.60 0.00
18 Laxmi Dental Limited Bizdent Devices Private Limited Subsidiary Purchase of goods or services NA 63.40 0.10 1.10
19 Laxmi Dental Limited Rich Smile Design LLP Subsidiary Purchase of goods or services 3.00 Approved 11.80 26-03-2026 9.30 0.00 9.70
20 Laxmi Dental Limited Laxmi Dental Lab USA INC Subsidiary Sale of goods or services 2,337.70 Approved 2,363.50 07-05-2026 2,363.50 796.30 49.70
21 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Sale of goods or services 85.50 Approved 62.90 6.20 5.60
22 Laxmi Dental Limited Bizdent Devices Private Limited Subsidiary Sale of goods or services NA 396.10 122.90 36.00
23 Laxmi Dental Limited Rich Smile Design LLP Subsidiary Sale of goods or services 43.00 Approved 6.60 2.00 0.00
24 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Sale of goods or services 373.00 Approved 38.00 0.00 1.10
25 Laxmi Dental Limited Laxmi Dental Lab USA INC Subsidiary Any other transaction Other income 185.10 Approved 171.90 0.00 0.00
26 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Interest received Approved along with terms of loan 6.60 0.00 0.00
27 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Any other transaction Rental Income 4.50 Approved 1.30 26-03-2026 5.80 0.00 0.00
28 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Any other transaction Security Deposit Approved 2.90 26-03-2026 2.90 0.00 2.90
29 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Loan Approved 50.00 50.00 100.00 Inter-corporate deposit 10.500 5 years from date of disbursement Unsecured For principal business activities
30 Laxmi Dental Limited Laxmi Dental Lab USA INC Subsidiary Investment 857.00 Approved 857.00 648.20 1,505.20
31 Laxmi Dental Limited Signature Smiles Dental Clinic Private Limited Subsidiary Investment NA 0.00 700.00 700.00
32 Laxmi Dental Limited Bizdent Devices Private Limited Subsidiary Investment NA 4,091.50 351.00 4,442.50
33 Laxmi Dental Limited Rich Smile Design LLP Subsidiary Investment NA 0.00 0.70 0.70
34 Laxmi Dental Limited Kids E Dental LLP Jointly controlled Entity Investment NA 0.00 3.00 3.00
35 Laxmi Dental Limited IDBG AI Dent Global Private limited Associate Investment 200.10 Approved 200.10 0.00 200.10
36 Laxmi Dental Limited Bizdent Devices Private Limited Subsidiary Any other transaction ESOP reimbursement NA 181.60 102.60 79.00
Total value of transaction during the reporting period 9,200.00